|
Symbol
|
RMAFFV | RMA9EV | RMASDV | RMBQSV | ABKBTQ | PHKRCH | RMADDV | RMAH4V | RMBHZV | PMXRCH | RMA3WV | RMBSMV | PSNRCH | PTDRCH | RMAVPV | ACJMTQ | MBUDJB | ACTKTQ | RMAXZV | Z0AYWZ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible |
|
Underlying
|
Alcon / Galderma Group AG / Sandoz Group AG | Douglas Hldg. AG / Galderma Group AG / UNILEVER TMICC BASKET | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | CREDIT SUISSE UBS MERGER / DOCMORRIS AG / Galderma Group AG | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG | Galderma Group AG / Sandoz Group AG / Sanofi S.A. | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Galderma Group AG / Givaudan / Straumann Hldg. AG | DOCMORRIS AG / Galderma Group AG / Sandoz Group AG | Galderma Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG / SIG Combibloc | Compagnie Financière Richemont SA / Galderma Group AG / Givaudan | Galderma Group AG / ON Holding AG. / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Novartis AG | Galderma Group AG / Sandoz Group AG | Compagnie Financière Richemont SA / Galderma Group AG / L'Oréal S.A. / LVMH Moet Hennessy Louis Vuitton | Galderma Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG / SIG Combibloc | Galderma Group AG / Sandoz Group AG / Ypsomed Hldg. AG | Compagnie Financière Richemont SA / Galderma Group AG / Lonza Group N / Swatch Group I | Bayer AG / Galderma Group AG / Galenica AG / L'Oréal S.A. | Accelleron Industries AG / Galderma Group AG / Givaudan |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
29.06.2026 | 28.09.2026 | 11.05.2026 | 18.05.2026 | 12.11.2026 | 02.09.2026 | 05.01.2027 | 10.07.2026 | 17.07.2026 | 24.07.2026 | 17.07.2026 | 07.08.2026 | 03.12.2026 | 03.06.2026 | 22.03.2027 | 17.09.2026 | 28.09.2026 | 01.10.2026 | 28.09.2026 | 08.07.2027 |
| Bid | 61.90 | 51.90 | - | - | 96.53 | 81.75 | 98.20 | 94.70 | 74.70 | 64.43 | 97.70 | 56.70 | 95.94 | 101.20 | 92.10 | 68.92 | - | 100.32 | - | - |
| Ask | - | - | - | - | 97.33 | - | 99.20 | 95.70 | - | - | 98.70 | - | 96.74 | - | 93.10 | - | - | 101.13 | - | - |